DEFINITIVE CONTRACT
Active75F40126C00054
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$1.5M
obligated · signed 3 months ago
EO 14398 FY26 BAA: NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION (BAA FY26C1BP4)
Performance timeline
Start
Sep 1, 2026
End
Aug 31, 2028
with all options
Loading status
Estimated start: Aug 31, 2027
NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC
Contract 75F40126C00054
UEI
RKVKGV1CJDB8
Parent Company
NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC
Capabilities & Certifications
Headquarters Location
Congressional District: 05
Current Obligation
$1,517,240
Base + Exercised Options
$1,517,240
Total Ceiling Value
$1,517,240
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
Place of Performance
Congressional District: 05
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.